Tocqueville Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.5M Sell
82,830
-2,422
-3% -$1.16M 0.55% 46
2026
Q1
$41.9M Buy
85,252
+4,521
+6% +$2.45M 0.62% 42
2025
Q4
$46.8M Sell
80,731
-4,314
-5% -$2.44M 0.68% 32
2025
Q3
$41.2M Sell
85,045
-12,064
-12% -$5.62M 0.6% 37
2025
Q2
$39.4M Buy
97,109
+16,636
+21% +$6.96M 0.6% 40
2025
Q1
$40M Buy
80,473
+4,790
+6% +$2.59M 0.65% 42
2024
Q4
$39.4M Buy
75,683
+3,553
+5% +$1.95M 0.62% 42
2024
Q3
$44.6M Sell
72,130
-3,733
-5% -$2.21M 0.7% 36
2024
Q2
$42M Sell
75,863
-1,060
-1% -$607K 0.69% 34
2024
Q1
$44.7M Buy
76,923
+323
+0.4% +$181K 0.73% 31
2023
Q4
$40.7M Sell
76,600
-16,998
-18% -$8.23M 0.74% 31
2023
Q3
$47.4M Buy
93,598
+9,875
+12% +$5.26M 0.9% 22
2023
Q2
$43.7M Buy
83,723
+7,248
+9% +$3.91M 0.78% 27
2023
Q1
$44.1M Buy
76,475
+5,752
+8% +$3.24M 0.83% 26
2022
Q4
$38.9M Sell
70,723
-2,035
-3% -$1.08M 0.74% 30
2022
Q3
$36.9M Sell
72,758
-1,115
-2% -$624K 0.75% 29
2022
Q2
$40.1M Sell
73,873
-302
-0.4% -$166K 0.73% 33
2022
Q1
$43.8M Sell
74,175
-858
-1% -$493K 0.66% 36
2021
Q4
$50.1M Sell
75,033
-934
-1% -$583K 0.69% 32
2021
Q3
$43.4M Sell
75,967
-1,587
-2% -$871K 0.64% 36
2021
Q2
$39.1M Sell
77,554
-916
-1% -$432K 0.57% 38
2021
Q1
$35.8M Sell
78,470
-816
-1% -$389K 0.55% 38
2020
Q4
$36.9M Sell
79,286
-1,240
-2% -$581K 0.62% 33
2020
Q3
$35.6M Sell
80,526
-2,724
-3% -$1.13M 0.68% 33
2020
Q2
$30.2M Sell
83,250
-2,201
-3% -$738K 0.63% 34
2020
Q1
$24.2M Sell
85,451
-5,472
-6% -$1.73M 0.6% 40
2019
Q4
$29.5M Sell
90,923
-17,301
-16% -$5.25M 0.43% 60
2019
Q3
$31.5M Sell
108,224
-8,204
-7% -$2.35M 0.43% 61
2019
Q2
$34.2M Sell
116,428
-729
-0.6% -$201K 0.44% 62
2019
Q1
$32.1M Sell
117,157
-4,167
-3% -$1.04M 0.43% 63
2018
Q4
$27.2M Sell
121,324
-24,949
-17% -$5.85M 0.41% 75
2018
Q3
$35.7M Sell
146,273
-10,372
-7% -$2.39M 0.45% 57
2018
Q2
$32.4M Sell
156,645
-11,030
-7% -$2.34M 0.41% 65
2018
Q1
$34.6M Sell
167,675
-7,867
-4% -$1.65M 0.44% 61
2017
Q4
$33.3M Sell
175,542
-34,063
-16% -$6.53M 0.38% 79
2017
Q3
$39.7M Sell
209,605
-9,839
-4% -$1.78M 0.46% 61
2017
Q2
$38.3M Sell
219,444
-5,911
-3% -$993K 0.46% 56
2017
Q1
$34.6M Sell
225,355
-16,254
-7% -$2.48M 0.42% 61
2016
Q4
$34.1M Buy
241,609
+17,750
+8% +$2.62M 0.44% 61
2016
Q3
$35.6M Sell
223,859
-11,517
-5% -$1.77M 0.43% 60
2016
Q2
$34.8M Buy
235,376
+1,564
+0.7% +$231K 0.41% 59
2016
Q1
$33.1M Buy
233,812
+14,782
+7% +$1.98M 0.44% 59
2015
Q4
$31.1M Buy
219,030
+25,024
+13% +$3.34M 0.42% 65
2015
Q3
$23.7M Buy
194,006
+8,180
+4% +$1.07M 0.32% 97
2015
Q2
$24.1M Buy
185,826
+65,872
+55% +$8.59M 0.28% 113
2015
Q1
$16.1M Buy
119,954
+65,059
+119% +$8.39M 0.19% 147
2014
Q4
$6.88M Sell
54,895
-3,371
-6% -$410K 0.07% 270
2014
Q3
$7.09M Buy
58,266
+1,806
+3% +$220K 0.08% 245
2014
Q2
$6.66M Buy
56,460
+9,130
+19% +$1.07M 0.06% 272
2014
Q1
$5.69M Sell
47,330
-8,525
-15% -$1.01M 0.07% 234
2013
Q4
$6.22M Sell
55,855
-2,743
-5% -$273K 0.08% 221
2013
Q3
$5.4M Sell
58,598
-57,858
-50% -$5.23M 0.07% 287
2013
Q2
$9.86M Buy
+116,456
New +$9.69M 0.13% 189

Other funds holding TMO

Tocqueville Asset Management's TMO Position: Q2 2026 in Review

Tocqueville Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, selling an estimated $1.16M and leaving 82,830 shares worth $41.5M. The position accounts for 0.55% of the portfolio, ranked #46.

Tocqueville Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $50.1M in Q4 2021. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Tocqueville Asset Management held 82,830 shares of Thermo Fisher Scientific worth $41.5M as of Q2 2026.
  • Tocqueville Asset Management sold 2,422 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.16M.
  • Thermo Fisher Scientific made up 0.55% of Tocqueville Asset Management's portfolio in Q2 2026, its #46 holding.
  • Tocqueville Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Tocqueville Asset Management's Thermo Fisher Scientific position peaked at $50.1M in Q4 2021.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.